TOREEND COZZI: Open Payments
NPI 1881460004 · NILES, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,218 in 119 payments from 47 companies in 2025. Trend: 2023 $29 · 2024 $2,638 · 2025 $3,218
Food & beverage: $2,992Education: $226
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $236 |
| Novartis Pharmaceuticals Corporation | 11 | $234 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $198 |
| Incyte Corporation | 7 | $183 |
| Regeneron Healthcare Solutions, Inc. | 5 | $179 |
| AstraZeneca Pharmaceuticals LP | 4 | $167 |
| Janssen Biotech, Inc. | 6 | $147 |
| Celgene Corporation | 5 | $138 |
| Genentech USA, Inc. | 5 | $119 |
| Merck Sharp & Dohme LLC | 4 | $92 |
Products named: LIBTAYO, REBLOZYL, Venclexta, ICLUSIG, TECVAYLI, JAKAFI, IBRANCE, Fabhalta.
Industry payments across IL — which companies pay providers there.
